相关实验视频
Updated: Mar 15, 2026
04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
1.6K
miR-146a-3p通过抑制BDNF驱动主要抑郁症病原体:一种新的诊断和治疗标
Kangjun Sun1, Tong Qin1, Zhenhui Kang1
1School of Food and Liquor Engineering, Sichuan University of Science &Engineering, Yibin 644005, Sichuan, China.
Gene
|March 13, 2026
概括
这项研究确定了microRNA-146a-3p (miR-146a-3p) 作为主要抑郁障碍 (MDD) 的关键调节者. 抑制miR-146a-3p和增强脑衍生神经营养因子 (BDNF) 显示出治疗MDD的前景.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 大型抑郁症 (MDD) 影响全球超过3.22亿人,是一个重大的健康挑战,自杀死亡率为15%.
- 微RNA (miRNA) 越来越多地与神经精神疾病有关,但miR-146a-3p在MDD中的特定作用仍然不清楚.
研究的目的:
- 调查miR-146a-3p在重大抑郁症 (MDD) 病变发生过程中的作用.
- 探索miR-146a-3p作为MDD的潜在诊断生物标志物和治疗点.
主要方法:
- 综合多数据库生物信息学分析和实验验证.
- 使用MDD的体内小鼠模型,双露西法酶记者测定和体外转染实验.
- 通过开放场地,强迫游泳和尾部悬挂测试来评估行为变化.
主要成果:
- 在MDD模型小鼠中,miR-146a-3p被显著上调,而脑衍生神经营养因子 (BDNF) 被下调.
- miR-146a-3p直接抑制BDNF的表达,通过减少关键的突触蛋白 (PSD95,SYN-1) 来损害突触可塑性.
- 在小鼠体内注射miR-146a-3p对抗体或BDNF蛋白改善了类似抑郁的行为,并恢复了突触功能.
结论:
- miR-146a-3p通过抑制BDNF依赖的突触可塑性,作为MDD病变发生的关键表观遗传调节剂.
- 通过对抗米尔抑制这种途径的可逆性突显了miR-146a-3p作为MDD的诊断生物标志物和治疗点的潜力.
- 这些发现为开发基于miRNA的情绪障碍干预措施提供了基础.
相关概念视频
01:18Depression: Overview
1.1K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.1K
01:27Depressive Disorders: Etiology
827
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
827
01:23Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K